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ABSTRACT 
The purposes of our research were: 
1. To develop an economical, easy to use, automated, high throughput system for 
large scale protein crystallization screening. 
2. To develop a new protein crystallization method with high screening efficiency, 
low protein consumption and complete compatibility with high throughput screening system. 
3. To determine the structure of lactate dehydrogenase complexed with NADH by x-
ray protein crystallography to study its inherent structural properties. 
Firstly, we demonstrated large scale protein crystallization screening can be 
performed in a high throughput manner with low cost, easy operation. The overall system 
integrates liquid dispensing, crystallization and detection and serves as a whole solution to 
protein crystallization screening. The system can dispense protein and multiple different 
précipitants in nanoliter scale and in parallel. A new detection scheme, native fluorescence, 
has been developed in this system to form a two-detector system with a visible light detector 
for detecting protein crystallization screening results. This detection scheme has capability of 
eliminating common false positives by distinguishing protein crystals from inorganic crystals 
in a high throughput and non-destructive manner. The entire system from liquid dispensing, 
crystallization to crystal detection is essentially parallel, high throughput and compatible with 
automation. The system was successfully demonstrated by lysozyme crystallization 
screening. 
Secondly, we developed a new crystallization method with high screening efficiency, 
low protein consumption and compatibility with automation and high throughput. In this 
crystallization method, a gas permeable membrane is employed to achieve the gentle 
evaporation required by protein crystallization. Protein consumption is significantly reduced 
to nanoliter scale for each condition and thus permits exploring more conditions in a phase 
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diagram for given amount of protein. In addition, evaporation rate can be controlled or 
adjusted in this method during the crystallization process to favor either nucleation or 
growing processes for optimizing crystallization process. The protein crystals gotten by this 
method were experimentally proven to possess high x-ray diffraction qualities. 
Finally, we crystallized human lactate dehydrogenase 1 (H4) complexed with NADH 
and determined its structure by x-ray crystallography. 
The structure of LDH/NADH displays a significantly different structural feature, 
compared with LDH/NADH/inhibitor ternary complex structure, that subunits in 
LDH/NADH complex show open conformation or two conformations on the active site while 
the subunits in LDH/NADH/inhibitor are all in close conformation. 
Multiple LDH/NADH crystals were obtained and used for x-ray diffraction 
experiments. Difference in subunit conformation was observed among the structures 
independently solved from multiple individual LDH/NADH crystals. 
Structural differences observed among crystals suggest the existence of multiple 
conformers in solution. 
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CHAPTER 1 GENERAL INTRODUCTION 
DISSERTATION ORGANIZATION 
Starting with a general introduction about structural proteomics, x-ray protein 
crystallography and related techniques, this dissertation continues with three complete 
scientific manuscripts in the following chapters. A final chapter summarizes the work and 
provides some prospects for future research. 
STRUCTURAL PROTEOMICS 
High Throughput Structure Determination 
To realize the real value of the wealthy genome sequence information obtained from 
several completed genome projects, the sequences must be correlated to the proteins they 
encode and the biological functions of those proteins. Since protein structure determines its 
function, large scale protein structure determination with the goal of establishing structural 
function relationships, termed as structural proteomics, has been the natural progression to 
further characterize the genome in this post-genomic era [1-5]. 
Protein structure is better conserved than sequence in evolution, comparing protein 
structures can reveal homology undetectable by sequence comparison and thus can quickly 
suggest the biological function of an uncharacterized protein [2], Protein structure and 
function relationship can also increase understanding of protein design principles and could 
have application in protein engineering [3]. Protein structure also provides a direct insight 
into the molecular mechanism of important biological processes [2], In pharmaceutical 
industry, protein structure could guide lead molecules optimization process, which has been 
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proven to be a very challenging task. This strategy of structure-guided or rational drug design 
has been demonstrated by the success in finding inhibitors for influenza virus neuraminidase 
and inhibitors for HIV proteinase [4, 9]. 
X-RAY PROTEIN CRYSTALLOGRAPHY 
The current primary methods for three dimensional protein structure determination 
are x-ray protein crystallography and NMR [5]. Protein structure determination by x-ray 
crystallography requires a protein crystal in good quality with a reasonable size. NMR is a 
technique for structure determination from a protein in solution. The difficult protein 
crystallization process is not required by NMR. However, NMR is normally limited to 
proteins with molecular weights less than 3OK [5]. In contrast, x-ray crystallography can 
determine protein structure with almost any molecular weight and complexity as long as a 
well ordered crystal can be obtained. This makes x-ray crystallography the working horse for 
most protein structure determination nowadays. 
History of Protein Crystallography 
X-ray crystallography has been an extremely successful technique for small molecule 
structure determination for more than 70 years [6], However, protein crystallography is a 
relative young technique. Although the first published observation of protein crystallization 
was in 1840 [7], the first protein structure, that of myoglobin, was solved by x-ray 
crystallography in 1960, only 46 years ago. Since then, protein crystallography has been used 
for the determination of more than 15,000 protein structures [5, 6], 
In the past two decades, protein crystallography was revolutionized by the advances 
of data collection and computing techniques [6], The traditional phasing problem of protein 
crystallography becomes easier because of the emergence of a multiple-wavelength 
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anomalous diffraction (MAD) technique [8, 14], which benefits from the availability of a 
tunable x-ray source from synchrotron radiation and the protein expression technique for 
incorporating seleno-methionine into protein for anomalous scattering [8,14]. 
Principles of Protein Crystallography 
X-ray is electromagnetic wave in nature. X-ray diffraction by an atom is an 
interaction between the electrons of the atom and the electric and magnetic components of 
the x-rays. The electron of an atom oscillates with the same frequency under the influence of 
the electromagnetic wave of incident x-ray and thus absorbs energy and then emits radiation 
of the same frequency. The nucleus in the atom can also interact with electromagnetic wave, 
but it is so massive that its scattering is negligible. There is a relationship between the 
properties of the emitted radiation (diffracted x-ray light) and the electron density distribution 
in the atom. For x-ray light diffracted by a molecule, obviously, the properties of the emitted 
radiation would be decided by the electron density distribution or the structure of the 
molecule. Therefore, the information on the properties of the diffracted x-ray light can be 
used to trace back to the electron density distribution in the molecule and thus the molecular 
structure can be determined [6, 10, 11]. 
However, the scattered x-ray light by a single molecule is too small to be measured 
experimentally. If a large number of molecules scatter x-ray light in a cooperatively way so 
that all the scattered x-ray lights can be summed together in a constructive way (instead of 
canceling each other), the overall scattered or diffracted x-ray would be much larger than the 
x-ray light diffracted by a single molecule. If the number of the molecules in cooperation is 
large enough, the overall scattered x-ray light intensity would be large enough to be detected 
by a photon sensitive detector such as photographic film or charge coupled device (CCD). 
For those large numbers of molecules, in order to able to diffract x-ray light in a constructive 
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way, they have to be well ordered or located periodically in space. Such entity is essentially a 
crystal [6, 10, 11]. 
X-ray Sources and Detectors 
X-rays are electromagnetic radiation with wavelengths in the range from 1000 
angstrom to 0.1 angstrom. For x-ray crystallography, usually x-ray with wavelengths 
between 1.6 angstrom to 0.5 angstrom are used. In x-ray instrument for general laboratory 
use, the x-ray light is usually produced by a copper anode at 1.54 angstrom or molybdenum 
anode at 0.71 angstrom [6, 11]. 
X-ray generated in this way has limited intensity because of the limited rate of heat 
dissipation. It is usually difficult to grow large size protein crystals [7], Therefore, high 
intensity x-ray light is preferred for protein crystallography. In the past two decades, intense 
x-ray radiation from electron synchrotrons have become more and more popular in protein 
crystallography because of its nature of high intensity and tunability in wavelength [10,11]. 
X-rays with continuous wavelengths make the full range from 0.5 angstrom to 1.6 
angstrom fully accessible for use. More importantly, x-rays from synchrotron radiation are 
wavelength tunable. This makes an important phasing method named as multiple-wavelength 
anomalous diffraction (MAD) widely used, which makes the traditional phasing problem 
becomes much easier to solve [14]. 
Single Photon Counters were used in the early days of x-ray crystallography, 
providing very accurate measurement. However, it takes a long time (weeks) to finish one 
complete data set because of its sequential nature. 
Photographic film had been a classic detector for crystallography. It is an area 
detector. Though less sensitive, photographic film has superior resolution to modern area 
detectors. 
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Image plates as x-ray detectors have the advantage of one magnitude higher 
sensitivity and much larger dynamic range over photographic film. In addition, it is more 
sensitive at short wavelengths that make absorption correction unnecessary [10]. 
Charge coupled devices (CCD) have been used as the detectors. It is more sensitive 
than photographic film. It has large dynamic range, excellent spatial resolution, low noise 
level and fast data transfer rates [10]. 
Solving Structures 
The mathematical principles behind x-ray diffraction are not complicated. The 
diffraction pattern formed by a crystal is the Fourier transform of the crystal. However, in the 
x-ray diffraction experiments, only intensities of those diffracted x-rays are recorded on 
detectors. The phase information, which is critical for description of the diffracted x-ray is 
totally lost. It's not a real problem for small molecules because of the limited number of 
atoms involved in diffraction and thus limited possibilities of phases. However, for protein 
crystallography, the number of atoms in a protein molecule is very large and thus makes the 
phasing problem difficult to solve. 
Taking advantage of other information available, for protein crystallography, the 
following methods have been mainly used for solving the phase problem: Molecular 
Replacement, Isomorphous Replacement and Anomalous Scattering, 
Molecular Replacement 
If a similar protein structure is available, the structure of the unknown protein 
molecule can be solved by the method named molecular replacement solely from the 
intensities of diffraction pattern without any experimental or other phase information. This 
method has been getting more and more application with more protein structures determined 
resulting from the efforts of structural proteomics. 
6 
Isomorphous Replacement 
Based on the fact that more than 50% content of a protein crystal is solvent, M. F. 
Perutz [12, 13] developed a phasing method called Isomorphous Replacement. In this 
method, heavy atoms can be introduced into protein crystals by diffusion to generate crystal 
derivatives, which are structurally identical to the native crystal with the only exception of 
the presence of the heavy atoms. Since heavy atoms scatter x-ray light more strongly than 
light ones because of their higher atomic number, diffraction data from a series of crystal 
derivatives contain useful phase information sufficient for solving the structure of the native 
crystal. 
Anomalous Scattering 
There are two ways to use anomalous dispersion for phase determination: single-
wavelength anomalous dispersion (SAD) and multiple-wavelength dispersion (MAD). With 
the advent of powerful synchrotron radiation and protein expression technique, multiple 
wavelength anomalous scattering has almost become the standard method for phase 
determination. 
To use anomalous dispersion, anomalously scattering atoms are incorporated into 
recombinant proteins by replacing normal sulfur-containing methionine with selenium 
methionine. The selenium atoms normally sufficiently provide anomalous scattering in a 
crystal. For SAD, two data sets are collected on both native and derivative crystals. Only one 
wavelength is chosen. In a similar way to Isomorphous Replacement, phase information can 
be obtained. For MAD, since anomalous scattering power of selenium atoms is radiation 
wavelength dependent, a series of diffraction patterns with appreciable changes in intensity 
can be generated by simply varying the wavelength of incident x-ray synchrotron radiation 
[14]. Phase information can be obtained by solely using the anomalous dispersion as in MAD 
method. In a MAD structure determination, since only one crystal is used for the entire data 
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collection, isomorphism is perfect. Moreover, unlike isomorphous replacement, MAD can 
provide good phase information at high resolution [6, 14]. 
PROTEIN CRYSTALLIZATION 
Characteristics of Protein Crystals 
There are significant differences between protein crystals and small molecule 
(inorganic or organic) crystals in many aspects including physical (such as optical properties) 
and mechanical properties, growth mechanism and internal networks forming crystal lattice. 
Those differences have profound implications on protein growth methods, x-ray diffraction 
data collection strategies and data qualities [15-24], 
The striking and important difference between protein crystals and small molecule 
crystals is the high percentage of solvent in protein crystals, which is normally 50% to 70% 
[25]. This feature of protein crystals results in their unique diffraction and other physical 
properties. Protein crystals are thus mechanically very weak. Great care needs to be taken for 
protein crystal handling. Protein molecules in a crystal are surrounded by ordered, structural 
water molecules, which make the protein molecules still biologically active [27], and thus 
very likely have similar structures as in solution. 
Resulting from the large amount of solvent content, for storage or data collection, 
protein crystals must be preserved in an environment with humidity control or must be flash 
cooled at cryogenic temperature for keeping hydration and thus integrity. Otherwise, protein 
crystals will lose water and completely lose internal order and their diffraction capabilities. 
[28-34] 
There are fewer and weaker lattice constraints in a protein crystal than small molecule 
crystals. The interactions among protein molecules are also weak. Therefore, protein crystals 
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are generally less ordered and show lower diffraction qualities compared with traditional 
crystals [15-34], 
Principles of Protein Crystallization 
Some studies show protein growth mechanisms are similar to those for small 
molecule crystals, which include spiral dislocations, two-dimensional nucleation on surfaces, 
random nucleation and normal growth [19, 21, 35], 
It has been shown by AFM study that the characteristic kinetic parameters of protein 
crystal growth are significantly lower than those for traditional crystals by a factor of two or 
three magnitudes [15, 17, 36-41], In practice, small molecule crystals can grow in minutes or 
days while protein crystallization takes days to weeks or even months. 
Protein crystallization normally occurs at conditions at which protein molecules are in 
their native conformations. These conditions are normally neutral, biological pHs, biological 
temperatures and non-denaturing conditions. 
METHODS FOR PROTEIN CRYSTALLIZATION 
There are currently two main methods for protein crystallization: Vapor diffusion and 
microbatch. The main goal of these two crystallization methods is to achieve 
supersaturation at a slow rate since proteins take long time to crystallize (If the 
supersaturation is achieved too fast, precipitation instead of crystals will be obtained.). 
Vapor Diffusion 
There are two modes of this method: sitting-drop and hanging-drop. Usually two 
microliter protein solution is mixed with two microliter precipitant/well solution and then is 
dispensed to a siliconized cover slip. For hanging drop method, the mixed protein/precipitant 
solution drop is suspended by surface tension on the surface of an inverted cover slip, which 
9 
forms a close chamber by covering and sealing a well with precipitant solution inside. For 
sitting-drop method, the mixed protein/precipitant solution drop sitting on the bottom of a 
well is physically separated in solution phase from the precipitant solution by a barrier in the 
well, but it is connected in the air phase with the precipitant solution. Resulting from the 
difference in the concentration of precipitant, there is a vapor diffusion process occurring 
between two solutions in vapor diffusion methods. Since it is a slow vaporization process, it 
greatly favors the slow protein crystallization process. 
Vapor diffusion is a popular method for protein crystallization, especially for manual 
operation of the experiments. It is suitable for screening a large range. Moreover, it is 
economic, convenient and easy to perform manually. 
Microbatch 
To use this method, microliter protein solution is mixed with precipitant solution and 
then put in an oil drop. A series of precipitant concentrations will be used for screening 
purpose. But, for one drop, the concentration of the precipitant usually does not change much 
over the time. Basically only one condition is explored for each drop in the oil. The 
advantage of this method is that the best crystallization can be well defined in the screening 
experiments since the condition for each well is not changed over time. This is good for later 
optimization experiment to grow larger crystals. 
HIGH THROUGHPUT SCREENING FOR PROTEIN 
CRYSTALLIZATION 
Despite the great efforts on studying protein crystallization mechanisms [15, 17, 19, 
21,35-41], protein crystallization is still currently underdeveloped science, which is mainly a 
trial-and-error procedure [10]. 
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Currently, there is still no effective theories that can help predict protein 
crystallization conditions. Therefore, the practical strategy is to screen a large number of 
combinations of pH, salt concentration, précipitants and so forth. If any promising conditions 
are found, further finer screening will be executed with the goal of optimizing the condition 
for growing large size crystal for x-ray diffraction experiments. 
Problems of Current Methods 
The traditional crystallization methods such as vapor diffusion and microbatch 
method are currently employed for large scale crystallization screening. The mechanical 
operations required for applying these two methods are relatively complicated for 
automation. Therefore, in most efforts on achieving high throughput and automated 
crystallization screening, various robots are employed [42-49], 
Although the strategy of employing robots has achieved impressively high 
throughput, robots are expensive and demand professional maintenance from time to time 
and are not accessible for most biologists and regular users. The visible light detection 
method in those systems often encounters the difficulty of complicated background. In 
addition, for microbatch method, the crystallization components in the mother liquor 
sometimes can interact with oil and interfere with the crystallization process [50]. 
THE GOALS 
The first goal is to develop an economical, easy to operate, high throughput and 
automated system without using high cost high maintenance robots. The second goal is also 
to develop a new crystallization method that can provide high screening efficiency, low 
protein consumption, complete compatibility with automated, high throughput screening 
systems. The third goal is to develop a new detection scheme that can eliminate the common 
false positives but still work in a high throughput automated manner. 
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At last, the fourth goal is also to use protein crystallography tools to determine the 
structure of LDH/NADH complex in order to reveal the inherent structural properties of this 
important enzyme. 
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CHAPTER 2 AUTOMATED HIGH THROUGHPUT NANO 
LITER SCALE PROTEIN CRYSTALLIZATION SCREENING 
Fenglei Li and Edward S. Yeung* 
ABSTRACT 
A highly efficient method has been developed for automated and high throughput 
nanoliter scale protein crystallization screening. The overall system consists of liquid 
dispensing, crystallization and detection and serves as a whole solution to protein 
crystallization screening. The novel, cost-effective, high throughput, automated liquid 
dispensing system can dispense protein and multiple different précipitants in nanoliter scale 
and in parallel. A new detection scheme, native fluorescence, with a joint complementary 
visible light detection, has been employed in this system for detecting the protein 
crystallization screening results. The detection part has the capability of distinguishing 
protein crystals from inorganic crystals in a high throughput and non-destructive way. The 
whole method from liquid dispensing, crystallization, to crystal detection is essentially 
parallel, high throughput and automatic. The system was successfully demonstrated by 
lysozyme crystallization screening. 
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INTRODUCTION 
In the past few years, an incredible wealth of genetic sequence information enabling 
our better understanding on many living organisms has become available with the completion 
of several genome projects [1-3]. These genetic information must be correlated to the 
biological functions of the proteins they encode for realization of their real values [2], The 
biochemical functions of proteins, the working agents of life, are decided by their three 
dimensional structures [2]. Therefore, functional genomics or proteomics including the 
determination of three dimensional structures of protein has been considered the natural but 
critical next step after genome sequencing era [2], 
Structural proteomics is an effort to determine the three dimensional structures of 
proteins on a genome-wide scale in order to facilitate a better understanding of the 
relationship between protein sequence, structure and function [2], Several pilot structural 
proteomics, aiming to generate a set of experimentally determined and computationally 
augmented protein structures representing most tractable proteins, have been underway [1,2, 
4, 9]. 
There are two primary techniques at present available for three dimensional protein 
structure determination at atomic resolution—x-ray crystallography and nuclear magnetic 
resonance (NMR) [11]. X-ray crystallography can be used to determine the structures of 
those proteins crystallizable, which is the case for most globular proteins, regardless of 
protein size and complexity [11]. NMR can be employed to determine the structures of 
proteins in solution, which don't have to be crystallized. It has the advantage of defining 
some certain dynamic properties of proteins. But NMR is generally limited to proteins with 
molecular weight of less than 30 kDa [11]. 
Currently, the predominant method for determination of three dimensional structures 
of biological macromolecules is X-ray crystallography [12]. Significant advances have been 
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achieved in protein preparation, X-ray data analysis and so on [13]. However, protein 
crystallization still remains as a bottleneck of X-ray crystallography [13]. Protein 
crystallization is currently still a "black area" with trail-and-error processes. There is no 
theory or recipe that can effectively predict the conditions where a protein crystallizes [15]. 
The current method to get around this problem is to screen a large number of chemical and 
physical conditions such as pH, temperature, ionic strength and concentrations of precipitant 
and additives [14, 15] to determine the initial crystallization conditions. Obviously the 
number of conditions that need to be screened will be quickly added up at an exponential 
rate. This requires a large amount of protein. However, even though one employs the most 
recent methods for cloning and protein expression, only submilligram or lowmilligram 
proteins can be generated without stupendous expenditures of resources [19]. The 
conventional crystallization methods usually use microliter protein sample for each condition 
they screen. The availability of protein essentially limits the number of conditions that can be 
screened. The traditional methods such as vapor diffusion and microbatch method are also 
labor-intensive and time-consuming. Developing high throughput, automatic and 
miniaturized protein crystallization method is critical if one also considers the fact that there 
are about 20,000-25,000 protein-coding genes in human genome [22]. 
There are some efforts on improving the throughput of protein crystallization 
screening and decreasing protein consumption in recent years [15-19], However, most of 
them were involved in using sophisticated and expensive commercial liquid handling system 
in order to be able to deliver nanoliter solutions in a high throughput. These work employed 
the regular or modified vapor diffusion method or microbatch method, which usually 
requires sophisticated operations by expensive robots for automation. The visible light 
detection scheme employed in those work suffers the problems such as complicated 
background which makes crystal reorganization more difficult and incapability of 
distinguishing protein crystals from inorganic crystals. In those works, each well was 
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detected in a sequential way and thus the throughput is limited. In the current work, a novel, 
inexpensive and easy-made liquid handling system was introduced. This system has the 
capability to deliver multiple nanoliter protein solutions and précipitants simultaneously and 
thus significantly improves the throughput of protein crystallization screening. A brand new 
protein crystallization we just developed [20] is employed in this system. It is highly 
amenable to automation and high throughput and essentially eliminates the need for 
complicated robots. Moreover, here we introduce a brand new detection scheme, 
fluorescence detection, to protein crystallization screening research field. This detection 
scheme provides a novel capability of distinguishing protein crystals from inorganic crystals, 
which can't be done by the regular visible light detection scheme. The fluorescence detection 
designed in this system is especially highly compatible with automatic and high throughput 
protein crystallization screening. Working with a complementary visible light detection 
scheme in the same system, fluorescence detection provides a new but better solution for 
protein crystallization screening detection compared with the regular detection method. Each 
step in this system is especially suitable for automation and high throughput. The overall 
system provides a much better solution to every step required in protein crystallizations 
screening process: liquid handling, crystallization and detection. 
EXPERIMENTAL SECTION 
Parallel Liquid Handling System 
The liquid handling system consists of one syringe pump, two 81 -capillary bundles 
and 81 vials containing different précipitants (Table 1). Each vial is full of one kind of 
precipitant and has one capillary as inlet and one as outlet. Each vial is sealed by a cap. All 
inlet capillaries are connected to the syringe pump via PEEK tubing. All outlet capillaries are 
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fixed at a capillary array holder and carefully aligned so that all the openings are in the same 
plane. The syringe pump was controlled by a personal computer. A 5mL syringe was used on 
the syringe pump. The syringe pump was purchased from Kloehn Ltd, Las Vegas, NV. The 
capillaries were purchased from Polymicro (Polymicro Technologies, LLC, Phoenix, AZ), 
whose inner diameter is 250 micrometer and the outer diameter is 360 micrometer. PEEK 
tubing was purchased from Upchurch Scientific, Inc. (Oak Harbor, WA). The small CCD and 
the three dimensional translational stage was purchased from Edmund Optics. 
Before every use of this system, care was taken to make sure the syringe was full of 
water and free of air bubbles; all the inlet capillaries between the syringe and the vials were 
full of water and free of air bubbles as well; the vials were carefully filled with all kinds of 
précipitants desired for screening and free of air bubbles; each outlet capillary was filled with 
the precipitant which it is connected to and free of air bubble. 
81-weII Protein Crystallization Plate 
The protein crystallization plate is made of fused silica. The plate was made by 
ultrasonic machining because of the brittle property of fused silica. It has 9 by 9, totally 81, 
small wells. The diameter of each well is 1.2 mm and the spacing between wells is 500 nm. 
The depth of each well is 2.5 mm. The fused silica was purchased from Heraeus Optics, Inc. 
Before each use, the plate was carefully cleaned by an ultrasonic device. 
Fluorescence Detection System 
The detection system is showed as Figure 4. The excitation source is a 500 W Hg(Xe) 
Arc lamp(Oriel, Stamford, CT). An intense UV band (270-320 nm) comes from the lamp. 
Three optical filters were employed as excitation filters. These three filters are as follows: a 
color glass filter (UG-5, Schott Glass, Duryea, PA; 80% transmittance between 250-380 nm; 
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85% transmittance at 280 nm); a customized interference band-pass filter(Omega Filters, 
Brattleboro, VT; center wavelength: 280 nm, 20% transmittance; FWHM: 35 nm ); an 
interference band-pass filter (CVI, Albuquerque, NM; FWHM: 10 nm; center wavelength: 
280.0 nm.). The UV mirror (CVI, Albuquerque, NM) reflects 99% of the light between 250 
and 290 nm. A long-pass color glass filter (WG320, Melles Griot, Irvine, CA) and an 
Interference Filter (center: 350 nm, FWHM: 10 nm) serve as emission filters to block the 
scattering light. The native fluorescence from protein crystals is collected by a Nikon quartz 
camera lens (Nikon, f: 4.5, f.l.: 105 mm). A 16-bit, back-illuminated CCD camera (TE/CCD-
512-TKB, Princeton, NJ) is employed for the imagining. The CCD has about 40% quantum 
efficiency in UV region. 
Visible Light Detection System 
The visible light detection system is in the same system as shown in Figure 2. 
When visible light detection scheme is used, the UV light is blocked and vice versa. 
The light source for visible light detection is regular fluorescent luminaire. In the visible light 
detection mode, the emission filters used in fluorescence detection mode serve as neutral 
density filters. The same camera lens and CCD camera are used for imagining. 
Materials and Reagents 
Sodium phosphate was purchased from Fisher Scientific. TrisHCl 
(Tris(hydroxyl)aminomethane hydrochloride), sodium hydroxide, hydrochloric acid, sodium 
acetate, sodium chloride, HEPES (4-(2-hydroxyethyl)piperazine-1 -ethanesulfonic acid 
sodium salt) were purchased from Hampton Research, Inc. CHES(N-cyclohexyl-2-
aminoethanesulfonic acid), sodium citrate CAPS(N-cyclohexyl-3-aminopropanesulfonic 
acid), were purchased from Sigma. Lysozyme was purchased from Seikagaku Corporation. 
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All buffers were freshly prepared by adding appropriate aliquots of concentrated 
components purchased from Hampton Research Inc., Fisher Scientific and Sigma. The pHs 
were adjusted by adding appropriate amount of 1M sodium hydroxide or 1M hydrochloric 
acid solution purchased from Hampton Research Inc and were confirmed by a calibrated pH 
meter. 
Lysozyme solutions were prepared by dissolving powders in the appropriate buffer 
and then centrifuged to get rid of any solid substances. 
RESULTS AND DISCUSSION 
Parallel Liquid Aspiration and Dispensing 
The system is shown in Figure 1. Each vial containing one certain precipitant is 
sealed by a cap and thus a closed system with one inlet capillary and one outlet capillary 
forms. Care was taken to ensure that the capillaries and vials were free of air bubbles. 
Therefore, for each vial, the same amount of solution is pushed into the outlet capillary if 
there are some solution pushed into the vial from the inlet capillary since liquid is not 
compressible and the vial is sealed by the cap. The syringe pump is controlled by a personal 
computer. The total motion of the stepping motor in the syringe pump can be divided into 
48,000 steps. Therefore, each step of the stepping motor is responsible for about 0.104 uL 
(5000 uL is divided by 48000) solution dispensed to or aspirated from 81 capillaries. For 
each step of the stepping motor and each capillary, about 1.3 nL solution is aspirated from or 
dispensed into. Since the length, the inner diameter and inner surface friction are the almost 
same for all 81 capillaries, the volume of the solution aspirated or dispensed is the almost 
same for each individual capillary for each step of the motor (provided that the viscosity for 
the solution in each capillary is very similar; if not, the capillary bundle can be easily 
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designed to be heated up to lower the viscosity to make all solutions have similar viscosities). 
There is minute dilution because of the introduction of water from the syringe to each vial. 
The volume of each vial is about 1.8 mL, so the dilution factor is 1.33% if 24 uL is 
introduced to each vial. Practically, this system can simultaneously aspirate or dispense 81 
different solutions from 20 nL to 24 uL. The maximum volume is decided by the total length 
of the capillary and the tolerance of the dilution factor (for example, for 1.33% dilution factor 
and 50 cm capillary length, the maximum volume for each precipitant the system can handle 
is 24 uL.), 
Figure 2 shows the system dispenses lOOnL and 200nL solutions in parallel. A six-
way valve is employed on the syringe pump. One way is for aspirating water into the 5mL 
syringe. One way is for waste. One way is for connection to capillary bundle. The rest ways 
are not used. The system can aspirate water from an inlet water bottle and then dispense 
water into capillaries by switching between ways of the 6-way valve. The precipitant 
solutions in the 81 vials are replaced after certain time to avoid the excess dilution. 
The précipitants in vials are shown in Table 1. 
There is no fundamental reason that the system has to be limited to 81 wells. It could 
be further scaled up if larger syringe and more powerful syringe pumps are employed, which 
is usually not a problem at all. 
Crystallization 
A fused silica crystallization plate with 81 micro wells as described in the 
experimental section was employed for the protein crystallization screening experiments. 
Figure 3 shows the crystallization plate and its comparison with a traditional VDX 24-well 
crystallization plate and a penny coin. A 50mg/mL lysozyme solution is used for the 
demonstration. The liquid handling system described earlier was used to aspirate solutions 
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from sample reservoirs into each capillary in the capillary bundle and to dispense solutions 
from each capillary to the target micro well in the crystallization plate. 
Firstly, the outlet capillaries were fully filled with précipitants and then 100 nL water 
from a water reservoir was aspirated into each outlet capillary in the bundle. The 100 nL 
water plug in each capillary serves as an isolation layer between protein solution and the 
precipitant in each capillary to avoid the possible precipitation because of their direct contact. 
Second, the water reservoir was replaced with a lysozyme solution reservoir and 100 nL 
lysozyme solution is aspirated into each capillary. Third, the lysozyme solution reservoir was 
replaced with the 81-well crystallization plate. The alignment between the capillary array 
head and the crystallization plate was done by manual adjustment of the three dimensional 
translational stage, assisted by a small CCD camera and one TV monitor. After the alignment 
was done, 100 nL lysozyme solution was dispensed to each micro well on the crystallization 
plate. Fourth, 200 nL solution from each capillary was dispensed into a waste reservoir. Fifth, 
the waste reservoir was replaced by the crystallization plate again and 100 nL precipitant 
solution from each capillary was dispensed into each micro well on the crystallization plate. 
After liquid dispensing, there are 100 nL lysozyme solution and 100 nL certain 
precipitant in each micro well. The crystallization process was done by a new crystallization 
method described in our paper [19]. 
The time that crystallization process takes depends on the protein and précipitants 
used and other experimental factors such as temperature, pH, etc. For the system 
demonstrated here, it usually takes about three or four hours, which is usually faster than the 
traditional vapor diffusion method and microbatch method. 
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Fluorescence Detection System 
For the detection of protein crystallization screening, visible light microscopy is 
widely used [15-20]. In protein crystallization screening, people usually need to make a 
decision whether a crystal showing up is a protein crystal or an inorganic crystal coming 
from buffer or precipitant in order to know which direction the further screening should go. 
Currently, there are three methods available to know the answer. One is to mount the crystal 
in question on the X-ray instrument to take a look at the diffraction pattern. But this method 
is not amenable for high throughput or automation. Moreover, most of time crystals showing 
up in the screening experiments are small and may not be able to diffract light well on home 
X-ray instrument, which is usually the accessible resource for x-ray diffraction experiments. 
Another method is to use mechanical force to press the crystal to do so called "crush test". If 
one hears the sound of click or see the suspect crystal becomes several smaller crystals, then 
it's an inorganic crystal. If one sees the crystal becomes powder and does not hear anything, 
that means he just crushed "a perfect good protein crystal". Protein crystals are generally 
extremely expensive and very hard to crystallize. Therefore, developing non-destructive 
methods is highly desired. One commercial company markets one small molecule dye which 
can fill the solvent channels in protein crystals to make the protein crystals look blue. The 
dye won not give the inorganic salts a blue color because inorganic crystals do not have 
solvent channels inside [20] and thus the small molecule dye won not be able to get inside 
the inorganic crystals. This method is non-destructive, but it is not amenable to automation 
and high throughput. It is highly desired to develop a detection scheme which is not only 
non-destructive but also amenable to high throughput and automatic protein crystallization 
screening detection. Here we introduce the fluorescence detection to high throughput and 
automated protein crystallography research field. Complementarily working with the 
transmitted visible light detection method in the system, fluorescence detection mode allows 
instantly distinguishing protein crystals from inorganic crystals without any complicated 
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experimental operation, which all other traditional and current methods can not do, according 
to our knowledge, and thus enables high throughput and automatic detection of protein 
crystals in the crystallization screening processes. 
Figure 6 shows the comparison of the fluorescence image and the visible light images 
for the same set of crystals including one inorganic crystal, which is sodium chloride as an 
example here. All protein crystals show up in both fluorescence and visible light fluorescence 
images, but the inorganic crystal only shows up in the visible light image. By careful optical 
design, most of the Raleigh scattering lights from crystals (no matter from protein crystals or 
inorganic crystals) were not collected by the camera lens. There are three critical factors 
here: the excitation filter, the emission filter and the angle between the excitation beam and 
the crystallization plate. One color glass filter, one band-pass interference filter (FWHM: 35 
nm) and one narrow band interference filter (FWHM: 10 nm) are combined together to serve 
as the excitation filters so that only very narrow band light around 280 nm can pass through 
to reach the crystallization plate. Two optical filters worked together to only allow a narrow 
band of lights around 350 nm to pass through to reach the CCD camera. A angle of 30 
(roughly) between the excitation beam and the crystallization plate was chosen to reduce 
most of the scattering lights. The rest of the scattering lights are ignorable or can be easily 
distinguished from fluorescence by setting up a right cutoff threshold when images are 
processed. 
Visible Light Detection System 
There is also a visible light detection mode in this system since it can give different 
information than the fluorescence mode. Two complementary detection modes working 
together in the same system enables a better detection for protein crystallization screening, 
especially suitable for high throughput and automatic screening. The image of protein 
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crystals taken by the system in the visible light detection mode is shown in Figure 7. the 
quality of the image can be improved by improving the quality of camera lens, choosing the 
right intensity of visible light and the right neutral density filters. Any questionable images of 
subjects can be examined or even possibly identified by comparing both fluorescent image 
and the visible light image. 
CONCLUSION 
A novel high throughput system for protein crystallization screening was developed. 
The liquid handling subsystem is able to aspirate or dispense 81 different or the same 
solutions in a high throughput and parallel way. The minimum volume of the solutions the 
system can handle is up to 20 nL and the maximum is up to 24 uL. Employing small amount 
of protein as of nanoliter significantly reduces amount of the protein required and thus 
significantly increases the number of the conditions that can be screened. It also significantly 
reduces the time and efforts the cloning and protein expression require and thus speeds up the 
whole process of structure determination. A brand new detection method, fluorescence 
detection method, which is highly compatible with high throughput and automatic protein 
crystallization screening, was introduced. The two detection schemes working 
complementarily, the fluorescence and visible light methods, provide the system with the 
novel capability of distinguishing protein crystals from inorganic crystals in an automatic, 
non-destructive and high throughput way, which no other method can do. The whole system 
is cost effective. Each subsystem is especially designed and highly suitable for high 
throughput and automation. The crystallization of lysozyme was successfully demonstrated 
on this system. 
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Table 1 The recipe for all précipitants. The solutions shown in each row were prepared 
by the same buffer solution with different concentration of sodium chloride as shown in the 
top row. 
Solution A is 0.1 M sodium phosphate buffer with 0.1 M sodium acetate at pH2.6; 
Solution B is 0.1M sodium citrate buffer with 0.1M sodium acetate at pH3.6; 
Solution C is 0.1M acetate buffer with 0.1M sodium acetate at pH4.6; 
Solution D is 0.1 M sodium citrate buffer with 0.1 M sodium acetate at pH5.6; 
Solution E is 0.1 M sodium citrate buffer with 0.1 M sodium acetate at pH6.6; 
Solution F is 0.1M HEPES buffer with 0.1M sodium acetate at pH7.6; 
Solution G is 0.1M TrisHCl buffer with 0.1M sodium acetate at pH8.6; 
Solution H is 0.1 M CHES buffer with 0.1 M sodium acetate at pH9.6; 
Solution I is 0.1M CAPS buffer with 0.1M sodium acetate at pH10.6; 
0.4M 0.6M 0.8M 1M 1.2M 1.4M 1.6M 1.8M 2M 
2.6 A1 A2 A3 A4 A5 A6 A7 A8 A9 
3.6 B1 B2 B3 B4 B5 B6 B7 B8 B9 
4.6 CI C2 C3 C4 C5 C6 C7 C8 C9 
5.6 D1 D2 D3 D4 D5 D6 D7 D8 D9 
6.6 El E2 E3 E4 E5 E6 E7 E8 E9 
7.6 F1 F2 F3 F4 F5 F6 F7 F8 F9 
8.6 G1 G2 G3 G4 G5 G6 G7 G8 G9 
9.6 HI H2 H3 H4 H5 H6 H7 H8 H9 
11 11 12 13 14 15 16 17 18 19 
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FIGURE CAPTIONS 
Figure 1. Photography of the liquid handling system. Center, 81 vials containing 
different précipitants. Center up, two 81-capillary boundless serving as inlet 
and outlet. Left, computer-controlled syringe pump. Right, capillary array 
head, 81-well sample plate and a small CCD camera used for alignment 
between the capillary head and the crystallization plate. 
Figure 2. The first picture shows lOOnL different précipitants^lOOnL for each) were 
dispensed. The second picture shows 200nL each of different précipitants 
were dispensed. 
Figure 3. The 81-well fused silica crystallization plate is shown on the top. The bottom 
is the comparison of the crystallization plate, a penny coin and the traditional 
VDX 24-well plate. 
Figure 4. Photography of the detection system. Center top, water-cooled CCD camera. 
Center middle, quartz camera lenses. Other specific optic components are 
shown in Figure 3. 
Figure 5. The illustration of the detection system including both fluorescence and 
visible light detection schemes. 
Figure 6. The comparison of fluorescence image and visible light image of the same set 
of crystals. The top one is a visible light image and the bottom one is the 
fluorescence one. The crystal in the first well at the second row is an inorganic 
(NaCl) crystal. Exposure time: 300 sec. 
Figure 7. The image of crystals taken in the visible light detection mode. Exposure 
time: 20 sec. 
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CHAPTER 3 A NOVEL CRYSTALLIZATION METHOD FOR 
AUTOMATED, HIGH THROUGHPUT PROTEIN 
CRYSTALLOGRAPHY 
Fenglei Li, Howard Robinson1 and Edward S. Yeung 
ABSTRACT 
A new crystallization method highly amenable to automation and high throughput 
protein crystallography was developed. The novel crystallization mechanism by employing a 
gas permeable membrane to achieve the gentle evaporation required by protein 
crystallization was identified. Protein consumption is significantly reduced by employing 
only nanoliter protein solutions for each trial and by exploring more conditions in a phase 
diagram for each trial. The method provides the capability of evaporation control during the 
crystallization process, which can facilitate the nucleation and grown processes. The protein 
crystals gotten by this method were proven to possess high x-ray diffraction qualities. The 
method is also suitable for scale-up experiments. 
1 Biology Department, Brookhaven National Laboratory, Upton, NY 11973-5000 
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INTRODUCTION 
Recently it is determined that the human genome comprises approximately 20,000-
25,000 protein-coding genes [1], The human proteome dictated by these genes will be about 
30,000 to 100,000 proteins [2]. The structures and functions of most of them are unknown. 
Knowing the three dimensional structures, especially all the key "functional" sites, of 
proteins can facilitate understanding on the relationship between structure, function and 
sequence of protein. Knowing the structures of protein target and the protein-ligand complex 
enables organic chemists to optimize the drug candidates in a more prompt and efficient way 
[4]-
Structural proteomics or structural genomics has become more and more important 
recently as an important part of functional genomics, whose goals are to systematically and 
thoroughly study the distribution, modification and interaction of gene products in tissues 
[17]. 
Three techniques have been employed for protein structure determination: X-ray 
crystallography, nuclear magnetic resonance spectroscopy and mass spectrometry. X-ray 
crystallography has been the predominant and still remained as the only method for three 
dimensional structure determinations, at atomic resolution, of protein molecules with 
molecular weight larger than 30 OOODa regardless of complexity [4], 
In order to get the three dimensional structures of protein molecules by X-ray 
crystallography, diffraction quality protein crystals must be gotten. Most of the time, protein 
crystallization is one of the major "bottleneck" in the whole process of protein structure 
determination (which generally includes cloning, protein expression, purification, quality 
assessment, crystallization, synchrotron x-ray diffraction data collection and structure 
determination) [5]. 
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The process of protein crystallization generally includes nucleation, crystal growth 
and cessation of growth. There are a lot of parameters influencing the crystallization process. 
It is very difficult to predict the growth conditions. The science of protein crystallization is an 
underdeveloped area. Protein crystallization is mainly a trial-and-error procedure. 
Currently, people still rely on empirical method by screening a batch of conditions, 
which comprise a lot of sets of combination of pH, temperature, type and concentration of 
precipitant and additives and so on. Due to the large number and interdependence of all 
possible experimental parameters, an exponential explosion in the number of possible 
conditions to be tried occurs [12]. 
This kind of screening normally requires large amount of purified proteins (25-
300mg). However, the availability of proteins is usually limited by the cost or resources 
associated with protein expression and purification [3], 
Moreover, in this proteomic era, a huge number of new proteins need to be 
determined by x-ray crystallography. The goal of functional genomics approximately 
requires determination of about 16, 000 new protein structures which have been chosen as 
modeling templates to evenly cover protein space [10]. 
Therefore, it is critical to significantly reduce the amount of protein consumed in the 
high throughput screening [3] and to increase the degree of automation of the whole process 
in order to significantly increase the throughput of the whole profess of protein structure 
determination. 
Therefore, miniaturization and automation are the two key factors in developing 
methodologies and instruments in order to realize high throughput for protein structural 
biology. 
Currently, there are mainly two traditional methods employed for high throughput 
crystallization screening development: microbatch and vapor diffusion (hanging drop or 
sitting drop). Conventional crystallization trials typically use 1-2 uL of both protein and 
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reservoir solution in each hanging drop. Generally speaking, these two methods are executed 
by manual operations. 
For reduction in the protein consumption, there are some efforts aiming to minimize 
these two methods. R. Stevens [15] proved as less as 20nL of both protein and reservoir 
solution can be used for the method of vapor diffusion to do protein crystallization. They 
showed[15] employing smaller volume of protein solutions not only requires less protein and 
in turn allows an increase in the screening of crystallization trails but also promotes faster 
vapor-diffusion mediated equilibration and thus decreases the overall time necessary for 
crystallization trials. 
The consequence of that reduction in the time required for crystallization is a 
concomitant reduction in the degree of protein degradation by oxidation, deamidation, 
aggregation and denaturation, which is especially important for those proteolytically 
sensitive proteins [6], G. DeTitta et al showed [16, 18] a miniaturized version of microbatch 
crystallization method, which can use as less as 200nL protein solutions. 
To increase the throughput of protein crystallization screening by the traditional 
methods mentioned above, several groups have been developing automated systems which 
can perform fast and a large number of crystallization trials. G. DeTitta et al [18] reported an 
automated system which can perform 40,000 microbatch experiments per day. They use 
high-density microtiter plates to screen 1536 conditions for each protein. Syrrx, Inc. [6] 
developed an automated robotic crystallization system including a series of robotics 
workstations. This system can dispense nanoliter volumes of protein droplets (20-100 nL) at 
an increased rate of setting up a 96-well plate in 2 minutes for sitting-drop vapor diffusion 
protein crystallization screening experiment [6], 
However, sophisticated and expensive robots have to be employed [6] because of the 
relatively complicated operation that the two traditional methods require. Therefore, 
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developing novel crystallization methods, which are highly compatible with automation and 
high throughput are highly desired. 
Here, we report one new method for protein crystallization screening, especially 
suitable for automation and high throughput. It consumes very small amount of protein 
sample by reducing the amount of protein required for each trial and increasing the number 
of conditions one single trial can explore. 
EXPERIMENTAL SECTION 
Crystallization Plates 
Two crystallization plates were employed for crystallization experiment in this work. 
Both of them were made of fused silica, which were purchased from Heraeus Optics, Inc. 
They were made by ultrasonic machining method because of their inherent properties of 
brittleness. One of them has totally eighty-one, nine by nine, small wells. The diameter of 
each well is 1.2mm and the spacing between wells is 500nm. The depth of each well is 
2.5mm. The other one has twenty-five bigger wells. The diameter of each well is 2.4mm and 
the spacing is between wells is 750nm. The depth of each well is 3mm. The fused silica was 
purchased from Heraeus Optics, Inc. Before each use, the plate was carefully cleaned by an 
ultrasonic device. 
Gas Permeable Membrane 
The gas permeable membrane was originally designed for cell culture. It allows 
oxygen, carbon dioxide and water vapor to pass through. The moisture transmission rate is 700 
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grams per square meter per 24 hours with 100% relative humidity vapor contacting the 
adhesive underside of the membrane [7]. 
Liquid Dispensing System 
The same liquid handling system has been employed and described in our previous 
work [11].'The liquid handling system has the capability of aspirating or dispensing 
simultaneously different solutions from 20 nanoliter to approximately 24uL. 
Materials and Reagents 
Lysozyme was purchased from Seikagaku Corporation. CHES (N-cyclohexyl-2-
aminoethanesulfonic acid), sodium citrate CAPS(N-cyclohexyl-3-aminopropanesulfonic 
acid), were purchased from Sigma. Sodium hydroxide, trisHCl (tris(hydroxyl)aminomethane 
hydrochloride), hydrochloric acid, sodium chloride, sodium acetate, HEPES (4-(2-
hydroxyethyl)piperazine-l-ethanesulfonic acid sodium salt) (crystallization grade) were 
purchased from Hampton Research, Inc. Sodium phosphate was purchased from Fisher 
Scientific. 
Lysozyme solutions were freshly prepared before each experiment by dissolving 
powders in the appropriate buffer and then centrifuged to get rid of any solid substances. 
All buffers were freshly prepared by adding appropriate aliquots of concentrated 
components purchased from Hampton Research Inc., Fisher Scientific or Sigma. The pHs 
were adjusted by adding appropriate amount of 1M sodium hydroxide or 1M hydrochloric 
acid solution (crystallization grade, purchased from Hampton Research Inc.) and were 
confirmed by a calibrated pH meter. 
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RESULTS AND DISCUSSION 
Protein Crystallization 
In the vapor diffusion method (either hanging drop or sitting drop), the drop of the 
mixture of a protein and a precipitant solutions is equilibrated against the reservoir solution 
(the same as the precipitant in the drop but twice of the concentration), which results in a 
continuous concentration of the drop until the equilibrium is achieved [12]. The evaporation 
rate decreases with the difference in concentration of the precipitant decreasing [12]. The 
concentration of the protein and precipitant in the drop increases during the diffusion process. 
Therefore, each drop "sweeps" a range of conditions [13]. 
In the original microbatch method, the super saturation level is kept fixed from the 
beginning of mixing the protein and precipitant solutions until protein crystallizes out from 
the solution. So, one single trail of microbatch method "sweeps" less conditions than vapor 
diffusion method. Therefore, overall, microbatch method takes more trails, namely more 
protein and precipitant, to hit the right condition for protein crystallization. 
Moreover, R. Stevens et al developed a modified vapor diffusion method which 
significantly decreases the amount of protein required by each single trial when vapor 
diffusion method is employed [15]. However, microbatch method is better than vapor 
diffusion method in terms of amenity to automation since the latter is involved more 
complicated operation and requires more sophisticated and expensive instrumentation [14]. 
Like vapor diffusion method, there is a trend to develop miniaturized microbatch 
methods, for example, G. DeTitta et al reported one modified microbatch method under oil 
which only requires 200nl protein sample [16, 18]. Despite the small protein consumption 
and good amenity to automation, microbatch method has the problem of the interaction 
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between the oil and the ingredients in the mother liquor such as some widely used organic 
précipitants and some small volatile organic molecules soluble in oil [15]. 
More importantly, in the microbatch method, since there is no a graduated 
concentration process as that in the vapor diffusion method, the direct mixing two high 
concentration solutions, the protein and precipitant solutions, can result in crystal showers or 
even precipitation [15]. Therefore, to develop a new method possessing the advantages of 
both vapor diffusion method and microbatch method is highly desirable. 
There are some efforts on giving the capability of concentrating protein and 
precipitant to microbatch method have been reported [17, 18] by employing an oil layer of 
mixing two different types of oils such as silicon oil and paraffin oils. 
Here, we reported a novel protein crystallization method which can not only 
significantly reduce the protein consumption, have the capability of exploring more 
conditions for each single trial, but also be very amenable to high throughput and automation. 
Similar to the vapor diffusion method, it has the concentrating capability and thus it explores 
a range of conditions in the phrase diagram. 
Unlike the vapor diffusion method, our method does not stop the exploring process 
since it won't reach the equilibrium like the vapor diffusion method does. More importantly, 
unlike the vapor diffusion method, it does not require complicated mechanical operations and 
essentially eliminates the need of expensive robots for high throughput and automation. 
Since there is no oil layer in our method, there is no interaction between oil and the 
ingredients of protein crystallization solutions. 
Figure 1 shows the crystallization plate used for demonstration of this new 
crystallization method. It is made of fused silica which can facilitate the fluorescence 
detection method we recently developed [11]. It could be made of glass or plastic or anything 
that is transparent if a regular transmitted light microscopy is employed as the detection 
method. For this particular plate, there are 81 individual micro wells which can hold 81 
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different crystallization mother liquors. A high throughput and automatic dispensing multiple 
different crystallization mother liquors had been achieved by a system described in our recent 
work [11]. After dispensing solutions to the wells, a sticky gas permeable membrane can be 
applied on the surface of the plate. 
Figure 2 shows the configuration of the set up. In current experiment, 100 nL 50 
mg/mL lysozyme and 100 nL precipitant were mixed together. Since the water molecules in 
the mother liquor can diffuse out via the small pores on the gas permeable membrane, a slow 
evaporation resulting in concentrating the crystallization mother liquors can thus be achieved. 
If proper conditions are hit, protein crystals will show up in the micro wells. Since the only 
operation here is to apply the membrane to the plate, the whole process is very amenable to 
automation. Moreover, there are no fundamental reasons which can limit the number of 
micro wells that can be made on the plate. Therefore, this method is essentially suitable for 
high throughput. 
Since the gas permeable membrane is pseudo-transparent, a regular transmitted light 
microscope can be used directly for the detection. The membrane can also be peeled off to 
further facilitate the detection. We have shown [11] a fluorescence method can be employed 
as a complementary detection scheme to the regular transmitted light detection method for 
examining the protein crystallization screening results conducted on a fused silica plate. 
Therefore, this crystallization method is naturally amenable to multiple detection schemes 
and easy to achieve a better detection than other methods. 
Figure 3 shows some excellent lysozyme crystals we got by this method. 
X-ray Diffraction Experiment 
The diffraction quality of the lysozyme crystals were examined by X-ray diffraction 
experiments. Figure 4 shows one diffraction map got from a lysozyme crystal crystallized by 
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our new method. The x-ray experiment was done on a beam line at Brookhaven National 
Lab synchrotron radiation source. The crystal diffracts to 1.35 angstrom. 
This x-ray diffraction result proves the capability of our new method to generate well-
ordered high quality protein crystals. 
Evaporation Rate Control 
Figure 5 shows the schematic drawing of the phase diagram of different 
crystallization processes by the traditional vapor diffusion method (AB), the standard 
microbatch method (G) and our new method (AB, AC, AD, AE, AF). 
For the standard vapor diffusion method, once after the cover slip is closed, there is 
no control on the concentrating process, which is completely decided by the difference in 
vapor pressure between the drop and the reservoir solution. The concentrating process stops 
when equilibrium is reached. The process is showed as route AB. It's a "self-sweeping" 
process which screens more than one condition. 
In the original microbatch method, the concentration of the protein and precipitant 
don't change much after being mixed at the beginning of the experiment until there are some 
protein crystallize out from the mother liquor. It follows a route like G in Figure 5. Only one 
condition is tested for each single trial. Therefore, compared with the standard vapor 
diffusion method, less space in the phase diagram is explored. 
In our new method, depending on the relative rate of nucleation and evaporation, the 
actual process could take one of the different routes such as AC, AD, AE, AF showed in 
Figure 5, depending on the relative rate of evaporation and that of nucleation or 
crystallization of protein. Since the evaporation rate can be controlled by changing the pore 
sizes or distribution of pores, this new method allows different routes or more options for 
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exploring the phase diagram. This is important because this provides one more experimental 
parameter to vary in the crystallization screening experiments. 
Figure 6 shows three experiments in which different number of membranes were 
applied to the crystallization plate. Since the gas permeable membranes are sticky, one 
membrane can be applied to another one to form a two-layer membrane or more layers. One 
layer of membrane shows fastest evaporation rate. Two-layer membrane shows slower 
evaporation and the three-layer one had the slowest rate. This shows the gas transportation 
rate of the membrane was changed and thus changed the crystallization process. 
Therefore, to tailor the pore size of the membrane can essentially tailor the 
evaporation rate. Employing different membranes with different pore sizes at different stage 
of a crystallization process could essentially form a "evaporation gradient" which could 
allow a faster evaporation process at the very beginning and a slower evaporation rate for the 
later stage to facilitate the initial nucleation process and the later growth process since these 
two processes actually require different evaporation rates. 
Moreover, one single trail of crystallization process could have different evaporation 
rates for its different stages. So, it's possible to form a "evaporation gradient" by employing 
a membrane with smaller pores first and later to switch to a membrane with bigger pores 
since it's so easy to physically change the membrane without bring much disturbance to the 
solutions in the wells. 
Scale Up 
Generally larger volume of mother liquor yields bigger crystals, which can diffract 
light more strongly and thus provide high resolution data [12]. Therefore, scale-up capability 
is very important for a crystallization method when it is employed for growing the final 
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crystals used for data collection. Larger crystals were obtained in larger volume by this 
method. 
CONCLUSION 
A new crystallization method was developed. It is highly amenable to automation and 
high throughput protein crystallography because of its inherent properties. It significantly 
reduces the protein consumption by using nanoliter solutions. It further reduces the total 
protein consumption by exploring more space in a phase diagram for each single trial. It 
provides one more parameter to take into control in crystallization screening experiments, 
which is the evaporation rate control. The protein crystals gotten by this method exhibits 
excellent x-ray diffraction quality. This method has also excellent scale up capability. 
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FIGURE CAPTIONS 
Figure 1. The images of the crystallization plate (a) and the plate covered by a gas 
permeable membrane (b) 
Figure 2. The schematic drawing of the configuration of each micro well on the 
crystallization plate. 
Figure 3. The images of lysozyme crystals crystallized by the new method. 
Figure 4. The X-ray diffraction map of a lysozyme crystal crystallized by our new 
crystallization method. 
Figure 5. The schematic drawing of a protein phase diagram. AB represents the route 
which a protein crystallization process by standard vapor diffusion method 
takes. G shows the route taken by a standard microbatch method. AC, AD, AE 
or AF represents respectively the possible routes taken by our new 
crystallization method. 
Cstart is the concentration the mother liquor at the starting point of the 
crystallization experiment. 
Cfinal is the final concentration of the mother liquor when the crystallization 
process is stopped. 
Cp,start is the concentration of the protein solution at the starting point of the 
experiment. 
Cp,final is the concentration of the protein solution at the final point of the 
crystallization process. 
Figure 6. The images of lysozyme crystals crystallized under different conditions, (a) 
one membrane layer (b) two membrane layers (C) Three membrane layers, 
(a) 2 uL (1 uL 50 mg/mL lysozyme + 1 uL precipitant B7 ) 
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(b) 4 uL (2 uL 50 mg/mL lysozyme + 2 uL precipitant B7 ) 
(c) 6 uL (3 uL 50 mg/mL lysozyme + 3 uL precipitant B5) 
(d) 8 uL (4 uL 50 mg/mL lysozyme + 4 uL precipitant B7) 
Protein: 50 mL/mL lysozyme 
Precipitant: 
B7: 1.6 M NaCl in 0.1 M sodium citrate buffer with 0.1 M sodium acetate at 
pH 3.6; 
B5: 1.2 M NaCl in 0.1 M sodium citrate buffer with 0.1 M sodium acetate at 
pH 3.6; 
Figure 1 
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CHAPTER 4 STRUCTURE DETERMINATION OF HUMAN 
LACTATE DEHYDROGENASE COMPLEXED WITH NADH 
BY X-RAY CRYSTALLOGRAPHY 
Fenglei Li, Howard Robinson2 and Edward S. Yeung 
ABSTRACT 
Lactate dehydrogenase plays a vital role in crucial glycolysis in many species. Human 
lactate dehydrogenase 1 (H4) completed with NADH was crystallized and x-ray diffraction 
data were collected with the best resolution at 2.5 A. The structures were solved by 
molecular replacement. 
The structure of LDH/NADH displays significantly different structural features 
compared with that of LDH/NADH/inhibitor in that some subunits in LDH/NADH show 
open conformation or two conformations while the subunits in LDH/NADH/inhibitor show 
all close conformation. 
2 Biology Department, Brookhaven National Laboratory, Upton, NY 11973-5000 
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Multiple LDH/NADH crystals were obtained and employed for x-ray diffraction 
experiments. Difference in subunit conformation was observed in the structures 
independently solved from multiple individual LDH/NADH crystals. 
Structural differences observed among crystals suggest the existence of multiple 
conformers in solution. 
INTRODUCTION 
Lactate dehydrogenase (LDH) had been found in many species from mammal and 
plants to bacteria [1], LDH catalyzes the reversible oxidation of lactate to pyruvate with 
concomitant interconversion of coenzyme NADH to NAD+. NAD+ is required for 
glyceraldehydes-3-phosphate to be oxidized to 1,3-biphophoglycerate during glycolysis for 
production of ATP. The reaction LDH catalyzes serves as an important biological means in 
many species to regenerate NAD+ from NADH for glycolysis to produce energy under 
anerobic conditions. 
In animal, LDH exists as a tetramer in a 222 symmetry. Each of the four subunits of 
LDH could be one of the two types of genetically distinct subunits: M, H, whose 
corresponding genes are LDH-A, LDH-B respectively. Therefore, LDH exists in five 
isozymes resulting from the hybridization of H and M subunits. LDH (H4) is usually found 
predominant in mainly anaerobic tissues such as cardiac muscle while LDH (M4) is the 
major form in anaerobic tissues such as skeletal muscle and liver [5], In addition, there is the 
third type LDH , the X form, corresponding to the LDH-C gene and usually found in animal 
testes. Different isozymes have different kinetic properties [1], 
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Structures of LDH from various species such as pig, dog fish, human, mouse, 
Bacillus stearothermophilus, bifidobacterium and Plasmodium falciparum have been 
determined by x-ray crystallography. 
The catalytic mechanism of LDH has been studied by various methods such as 
fluorescence polarization, fluorescence quenching spectroscopy, stop-flow kinetics and 
mutagenesis [1, 3], A compulsory order of substrate binding with coenzyme first was 
identified. Although series of steps were suggested for the reaction, the rate-limiting step has 
not been well determined. 
Based on the comparison between the structure of dog fish apoenzyme LDH M4 and 
that of an abortive ternary complex of LDH/NAD/pyruvate , the conformational change in 
the ternary complex was proposed to be induced by the coenzyme binding [2]. Later on, 
based on the information obtained from mutagenesis study [3, 17], the conformational 
change was proposed to be induced by the substrate binding for the case of LDH from 
Bacillus stearothermophilus [3]. The structure of apoenzyme LDH-C from mouse was found 
to be very similar to other LDH structures, surprisingly, however, the active site loop in this 
apoenzyme resembles not the "open" conformation found in apoenzyme dog fish LDH M4 
structure but the "induced" "close" conformation found in the ternary LDH complex 
structures [4], 
For the medical importance, Human LDH has been crystallized in the forms of H4 
and M4 complexed with NADH and an inhibitor, oxamate [5], The conformations of the 
active site loops in these two structures are all "close" as in the case of dogfish and porcine 
LDH[2]. 
To ultimately elucidate the reaction mechanism, structures of LDH in those important 
steps during the reaction coordinate could be of great value. However, in the current 
inventory of structures of LDH from mammal, there is no LDH/NADH binary structure yet. 
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This is largely because of the experimental difficulties of crystallizing LDH/NADH binary 
complex. However, valuable information regarding the active site could be missing because 
of the existence of inhibitor in the ternary complex since inhibitor has been thought to make 
the crystallization process easier by making LDH structure more rigid and thus the inhibitor 
could play a role in forming the ternary complex structure. 
With the high throughput capability of the screening method we have recently 
developed [13], we were able to screen a large number of crystallization conditions and 
successfully crystallize the LDH/NADH binary complex. 
In addition, our previous single molecule enzymatic kinetics study [9] suggests 
studying LDH and its binary complex with the coenzyme could reveal important information 
on the solution properties of protein molecules in terms of structure and function relationship. 
EXPERIMENTAL SECTION 
Materials and Chemical reagents 
Highly purified, isozyme grade lactate dehydrogenase 1 from human heart (H4-
hLDH) was purchased from Calzyme, Inc. NADH were purchase from Sigma. 
Crystallization grade sodium chloride, Tris (hydroxymethyl) aminomethane Hydrochloride, 
PEG 400, PEG 6000 were purchased from Hampton Research Inc. 
Crystallization of Lactate Dehydrogenase 
Lactate dehydrogenase was dialyzed for changing buffer, removing excess salt and 
increasing concentration to favor the thereafter crystallization experiments. LDH was 
dialyzed in 10 mM TrisHCl, 50 mM NaCl buffer in cold room for 30 hours. 
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LDH crystals were grown by hanging drop vapor diffusion method at room 
temperature. Six crystals of H4-hLDH were obtained by mixing equal volumes (2uL each) of 
a protein solution comprising 20 mg/mL H4-hLDH and 5mM NADH in lOmM TrisHCl, 
50mM NaCl at pH 8.0 and a well solution containing 20% PEG 4000 and 60% PEG 400 in 
0.20M TrisHCl at pH 8.1. One crystal of H4-hLDH was obtained by mixing equal volumes 
(2uL each) of a protein solution comprising 20 mg/mL H4-hLDH and 5mM NADH in lOmM 
TrisHCl, 50mM NaCl at pH 8.0 and a well solution containing 16% PEG 4000 and 60% PEG 
400 in 0.20M TrisHCl at pH 8.1. Crystals were blocks or rods of various approximate 
dimensions ~100um x ~50um x ~60um. 
Data Collection 
Crystals of H4-hLDH were flash cooled to liquid nitrogen temperature in their 
original crystallization mother liquor without adding anything else. X-ray diffraction 
experiments were done in a synchrotron beam at Brookhaven National Laboratory. The data 
were processed using HKL2000. Crystals were of P212121 symmetry. There is one 
homotetramer in the asymmetric unit. 
Structure Determination 
The structures of H4-hLDH were solved independently from seven independent x-ray 
diffraction data sets from seven crystals named as E, F, G, J, K, N, R. Seven structures were 
solved independently by molecular replacement with AMORE [6]. Graphical images of the 
structures were created by Pymol [10]. 
The coordinates of a homotetramer of human LDH/NADH/oxamate were employed 
as a search model [5], The molecular models were improved by refinements with CNS[7] 
and Xtalview [9]. Each subunit was treated independently throughput the refinement. The 
summary of final refinement statistics are shown in Table I. 
65 
RESULTS AND DISCUSSION 
Comparison of LDH/NADH and LDH/NADH/inhibitor structures 
Overall structures 
Human lactate dehydrogenase 1 (H4) is a homotetramer with 332 amino acid residues 
in each subunit and a molecular weight of 146K (formula weight 36559.6 for each subunit). 
In LDH/NADH complex, each subunit has an active site where it binds one NADH. The four 
active sites in H4 LDH from some species have been found to be independent, noninteracting 
binding sites [1] . 
Figure 1 shows the biological tetramer structure of H4 hLDH complexed with NADH 
at 2.5 A resolution determined by x-ray crystallography from the crystal named as "G". In 
this crystal structure, there is one homotetramer in each asymmetric unit. There is one NADH 
bound to each subunit. The space group is P212121. A summary of the crystallographic 
refinement is shown in Table I. 
The global characteristic of this structure is similar to those of LDH complexed with 
other ligands and inhibitors. Extensive secondary structures are found in this enzyme. Amino 
acid residues located in the helices account for approximately 40% of the total residues. Beta 
structures are responsible for approximately 23% of total residues [1]. As in the structures of 
LDH from human (LDH/NADH/inhibitor) and other mammalian species, in each subunit, 
there are two domains formed by residues 20-162, 248-266 and 163-247, 267-331 [5], The 
active site or substrate binding site is at the interface of the two domains. Six strands of 
parallel beta sheets form the NADH binding domain. As part of the domain. Residues 99-110 
form a loop which plays an important role in NADH, substrate binding and LDH catalytic 
reaction. 
For human lactate dehydrogenase 1 (H4), despite the large resemblance in global 
structure (Figure 2), in this study, a striking difference in terms of conformation of the active 
66 
site loop has been observed between the structures we determined from hLDH/NADH 
complex and those structures from LDH/NADH/inhibitor complex [5] . All active site loops 
(residues 99-110) in the four subunits are "closed" conformations in the human H4 
hLDH/NADH/inhibitor structures [5]. However, in the LDH/NADH structures we have 
determined from multiple crystals in this study, we found the active site loops are not always 
in closed conformations. In some subunits, the conformation of the active site loop is closed 
while in others it is either open or two-conformation (open and closed). 
Subunits with close conformation 
In the hLDH/NADH structure determined from crystal G, the conformation of the 
active site loop (formed by residues from 99 to 110) in subunit A, B, C and D is found to be 
two-conformation, closed, two-conformation, closed respectively. 
Figure 3 shows the closed conformation found in the subunit B of the structure 
determined from crystal G. Superposition of this structure with the structure of 
hLDH/NADH/inhibitor (Figure 4) shows the overall structural features are about the same. 
Those important residues located in the active site which are involved in catalytic reaction 
such as His 193, Arg 107, Arg 99 are in about the same positions. The coenzyme NADH is 
also located in about the same position. 
Subunits with open conformation 
Crystal K was obtained in the same drop (crystallization mother liquor) and was thus 
crystallized at exactly the same crystallization condition as crystal G. Two independent x-ray 
diffraction experiments were done on the two crystals and two data sets were independently 
processed. 
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Overlaying Subunit A Crystal IC with Subunit B Crystal G shows overall resemblance 
except one striking difference that the active site loop is in an open conformation in Subunit 
A Crystal K (shown in Figure 5) rather than a close conformation as shown in Subunit B 
Crystal G. In the open conformation, the active site loop is extended towards solvent and the 
distance between Glu 102 and its corresponding position in close conformation is more than 
10 angstrom. Both Arg 99 and Arg 107, the former related to NADH binding and the latter 
involved in stabilizing transition state [11] in the catalytic reaction, are located in this active 
site loop, therefore their positions are significantly different from those in a close 
conformation. 
In the structure of human H4 LDH/NADH/inhibitor, Arg 99 forms a hydrogen bond 
with the pyrophosphate of NADH and the guanidinium group of Arg 107 is within hydrogen 
bonding distance of both the reactive carbonyl of pyruvate and imidazole ring of the catalytic 
His 193 as in the structures of LDH from other species [3]. These interactions were thought 
to be important for the catalytic reaction in the way of stabilizing either substrate or transition 
state complex [3]. The observation that the position of 193 in an open conformation is the 
same as in a close one may indicate this residue is independent from substrate binding. It 
may be also independent of the conformation of the active site loop since its position is the 
same for both open and close conformation. 
Subunits with two conformations 
More interestingly, Subunit C Crystal G shows both open and close conformations. In the 
electron density map (Figured], in Subunit C Crystal G, the magnitude of the loop electron 
density in open conformation is estimated to be similar to that in the close one, but it is 
approximately half of that in Subunit B Crystal G. Moreover, the magnitude of the electron 
density of NADH in Subunit C Crystal G is about the same as that in Subunit B Crystal G. 
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This suggests the existence of two conformation in Subunit Crystal G is independent on the 
amount ofNADH bound. 
Comparison of multiple LDH/NADH structures 
To compare the structures from different crystals, subunit A in K and subunit B in G 
are overlaid as shown in Figure 6. Most parts of the two structures are similar and can be 
overlapped well, but the two loops show significant difference as large as 10 A. 
Figure 7 is the superposition of subunit B in K and subunit B in G. Both subunits 
have close conformations and the difference in these two subunits are inappreciable. 
The heterogeneity in loop conformation existing in one crystal and among multiple 
crystals could result from (1) sequence (2) crystallization conditions (3) amount ofNADH 
complexed with LDH (4) crystal packing. They are discussed as follows: 
Sequence 
The LDH in this study is a homotetramer. All crystals came from the same 
crystallization experiment and thus all crystals come from the same LDH solution. Therefore, 
all the sequences of the subunits should be the same. 
Crystallization conditions: 
Since both crystal G and crystal K were obtained from the same drop of 
crystallization mother liquor, crystallization condition is thus unlikely the reason. 
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Amount ofNADH complexed with LDH 
In crystal G, the amount (electron density) of NADH in Subunit B is about the same 
as that in subunit C. B shows one single close conformation, but C has two conformations. 
In crystal K, the amount of NADH in subunit A, which is an open conformation, is 
lower than NADH in other subunits in crystal K. It may seem the low amount of NADH is 
responsible for the open conformation. However, in crystal F (also crystallized at the same 
condition), NADH in subunit A is lower than that in other subunits, but subunit A is in two-
conformation and the electron density of the close conformation is stronger than the open 
one. Therefore, amount of NADH complexed with LDH is not correlated with a loop 
conformation. 
Crystal Packing 
If the difference in conformation results from crystal packing, then all the subunits 
located in the same location in the asymmetric unit should have the same conformation. 
However, this is not the case for the structures discussed here. For example, in crystal G, the 
conformations of four loops are two-conformation, close, two-conformation and close 
respectively. However, in crystal K, the conformations of subunits located at the 
corresponding positions are open, close, two-conformation and two-conformation. Two 
crystals have the same arrangement for the subunits in the asymmetric unit. Since the same 
location in the asymmetric unit doesn't lead to the same conformation, crystal packing should 
not the reason for the heterogeneity in loop conformation. 
Based on the analysis above, the existence of heterogeneity of loop conformation is 
seemingly due to the inherent properties of LDH itself, i.e. LDH may exists in multiple 
conformations in solution. Moreover, if the different conformera are in a fast equilibrium as 
suggested by traditional protein solution thermodynamics, the loop would not have been seen 
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in an x-ray crystal structure because of the time-averaging nature of the technique. Therefore, 
those conformers should be long-lived species in solution. 
CONCLUSION 
Human lactate dehydrogenase 1 complexed with NADH was successfully crystallized 
without adding any inhibitor and the best resolution of x-ray diffraction data is 2.5A. 
Heterogeneity in conformation of the active site loop has been observed among subunits in 
the same crystal and among multiple crystals. Existence of long-lived LDH conformers in 
solution is suggested. 
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Table 1. The resolutions of seven x-ray diffraction data sets collected on seven individual 
crystals and corresponding R factors and R free. 
e f G j K n r 
Resolution 2.9 2.8 2.5 2.8 2.6 3 2.8 
R .2284 .2267 .2194 .2307 .2369 2311 .2301 
R free .3166 .3101 .2790 .3172 .3027 .3140 .3156 
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FIGURE CAPTIONS 
Figure 1. This is the biological tetramer of LDH from crystal G. Each subunit is labeled 
by a different color. 
Figure 2. Superposition of crystal G (in green) with 1I0Z (in red). 
Figure 3. Loop (residue 99-109 shown in green) subunit B of crystal G. 
NADH is shown in blue. The loop has a close conformation. 
Figure 4. Superposition of Subunit B, Crystal G (green) with Subunit A, 
LDH/NADH/oxamate (red, 1IOZ) 
Figure 5. Subunit A of crystal K is shown in red, open conformation. NADH is in blue. 
Figure 6 Electron density map of Subunit C of Crystal G: two conformations 
Figure 7 Superposition of subunit A in K (red) and subunit A in G (green) 
Figure 8. Superposition of subunit B in K (red) and subunit D in G (green) 
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CHAPTER 5 GENERAL CONCLUSIONS 
An integrated system for protein crystallization screening at large scale in a high 
throughput manner was developed. The liquid handling subsystem has the capability of 
aspirating or dispensing 81 different or the same précipitants in a high throughput and 
parallel way. The volume range of solutions it can handle is between 20nL and 24uL. Small 
amount protein consumption as less as nanoliter for each condition significantly increases the 
total number of the conditions that can be screened. It also significantly reduces the time and 
efforts that cloning and protein expression require. 
A new detection method, native fluorescence, which is highly compatible with high 
throughput and automatic protein crystallization screening, was introduced. The two 
detection schemes, the fluorescence and visible light methods, working together 
complementarily provide the system with the novel capability of distinguishing protein 
crystals from inorganic crystals in an automatic, non-destructive and high throughput 
manner, which no other method can achieve at this time. The whole system is cost effective. 
Each subsystem is especially designed and highly suitable for high throughput and 
automation. The crystallization of lysozyme was successfully demonstrated on this system. 
A new crystallization method was developed. It is highly amenable to automation and 
high throughput protein crystallography because of its inherent properties. It significantly 
reduces the protein consumption by using nanoliter solutions. It further reduces the total 
protein consumption by exploring more space in a phase diagram for each single trial. It 
provides crystallographers one more parameter to take into control in crystallization 
screening experiments, the evaporation rate control. The protein crystals gotten by this 
method exhibits excellent diffraction quality. This method also has excellent scale up 
capability for growing large size crystals. 
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Human lactate dehydrogenase 1 (H4) complexed with NADH was successfully 
crystallized without adding any inhibitor and the best resolution of x-ray diffraction data is 
2.5A. Heterogeneity in conformation of the active site loop has been observed among 
subunits in the same crystal and among multiple crystals. Existence of long-lived LDH 
conformers in solution is suggested. 
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